chrisvoncsefalvay/vaers-outcomes huggingface dataset:
the nurse giving the vaccine she squeeze to get soft tissue of my upper arm and injected the COVID vaccine subcutaneously; fatigue; chills; lump in the arm; This is a spontaneous report from a contactable other healthcare professional (patient) via medical information team. A female patient (who was a respiratory therapist) of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via subcutaneous, administered in Arm on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 for covid-19 immunisation. Patient was a respiratory therapist and she stated that she had a second dose of vaccination on Saturday, and she know the instructions that it supposed to be given into the muscle, the deltoid muscle, intramuscularly, unfortunately when she got her second dose the vaccinator, the nurse giving the vaccine she squeezed to get soft tissue of her upper arm and injected the COVID vaccine subcutaneously and it did not go into the muscle. Patient was not worried about her arm, but what she worried about was the fact that the protection from the vaccine, comes from the vaccine going into the muscle which was highly vascularized, if her vaccine just went in to the fatty adipose tissue of the upper arm and not into the muscle would patient be still getting any protection from the second dose of the vaccine. Patient said that thousands and thousands of people had been received the vaccine incorrectly. She was concerned about one person in particular who had inadvertently received the vaccine subcutaneously instead of intramuscularly. She said that the person she was concerned about had been locked up for a year and now that he had taken the vaccine, he had a chance to go out but because of the AE, she was afraid the person may still be locked up. Patient also mentioned that this person had developed fatigue and chills after getting the vaccine. The person also had a lump in the arm. The outcome of all the events was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
On day #2 after second dose, I got a pain under my left arm (injection arm) in my arm pit area. It is painful and swollen, and appears to have fluid build-up.
Right hip pain   History of Present Illness: 90 year old female sustained mechanical fall on am 2/22/2023.  Radiographs apparently demonstrated a displaced  right intertrochanteric hip fracture . Patient last ate last night.  Was seen at hospital.  covid test taken there was negative.    Medications Prior to Admission: No outpatient medications have been marked as taking for the 2/22/23 encounter (Hospital Encounter).     Current Hospital Medications:   No current facility-administered medications for this encounter.     No current facility-administered medications for this encounter.     No current facility-administered medications for this encounter
Patient presented today (3-28-19) asking to speak to me who had immunized him on 2-22-19. He reported that he had quite a reaction to the SHINGRIX vaccine that I had given him. He explained that beginning the following day he experienced chills/fever/weakness and vision disturbances that continued to worsen in the following weeks until he was hospitalized with a flare of his myasthenia gravis during the week of March 18 through the 23rd. He reports his neurologist treated him with a 5 day series of IVIG. He was discharged on the 23rd improved but still experiencing vision disturbances, weakness, and balance issues. He is unable to drive.
Pt had onset of splotchy rash, swelling erythema and pain in immunized area.
MINUTES AFTER RECEIVING 2ND PFIZER COVID VACCINE PATIENT REPORTED FEELING NAUSEOUS AND LIGHTHEADED. HE SAT UNDER OBSERVATION FOR APPROX 15MINUTES. PATIENT DID NOT HAVE ANY OTHER SYMPTOMS OTHER THAN FEELING NAUSEOUS AND LIGHTHEADED. HE LEFT THE PHRMACY AS HE HAD SOMEONE WAITING FOR HIM AND I (THE PHARMACIST) CALLED TO FOLLOW-UP WITH HIM A FEW HOURS LATER BUT NO ANSWER.
Information has been received from a pharmacist (Pharm D.) concerning a 72 year old female with a drug hypersensitivity to KEPPRA, diazepam, and higher doses of aspirin and a history of epilepsy who on 07-NOV-2007 was vaccinated with pneumococcal 23v polysaccharide vaccine (lot# unknown). Secondary suspect therapy includes montelukast sodium (MSD). Other concomitant therapy included LYRICA, sertraline HCl, NASONEX, loratadine and AVAPRO. On 08-NOV-2007, the patient experienced a local injection site reaction. Medical attention was sought by the physician. The patient experienced a 4 inch diameter area of redness around the injection site associated with extreme pain and swelling. The pharmacist also noted that the area was warm to the touch. At the time of reporting the patient had not recovered. No further information was available. Additional information has been requested.
sick; This case was reported by a consumer via call center representative and described the occurrence of sickness in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient's friend. The age at vaccination was not reported. The patient got sick after receiving Shingrix. The reporter did not provide any additional details regarding the event or the patient.
Fatigue the next day, sore arm from time of injection for about 3 days after first shot. 2nd shot? just sore arm for a day.
She had gotten really high fevers around 104 and she was really fussy and was vomiting really bad. She also had dirrea almost everyday scince she had recivied the vaccine we took her to the emercancy once and the doctor just told us that it was the normal reaction the the vaccines she hsd recieved and just to give her alot of fluids. About a week later she died. The autopsy states SIDS.
Patient complained of mild itching on her throat. Patient has visible hives on forehead. Patient given Zyrtec 10mg PO. Patient vital signs 136/90, 80, 16, 98%. Patient monitored for 30 minutes in observation. Patient verbalizes, "I'm feeling okay now." Patient hives on forehead disappearing. Patient vital signs 122/86, 60, 8, 100% Patient denies itching feeling in throat. Patient educated on signs and symptoms of adverse reactions and when to seek medical attention. Patient verbalizes understanding.
After 10 minutes of having received it,  I became dizzy, sweaty and pale while seated, waiting to be discharged.  I was taken to the onsite ER.
Knot at injection site, diffuse bruise spreac down arm toward elbow (on anterior side). Not warm to touch and not overly sore (according to patient)
Body aches; Malaise; Fatigue; Low-grade fever; Headaches; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 01Apr2021 at 12:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis, psoriasis, gastroesophageal reflux disease (GERD), type 2 diabetes mellitus and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included duloxetine (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN) and vitamins nos/ minerals nos (CENTRUM); all for unknown indication from unknown date and unknown if ongoing. On 03Apr2021 at 20:00, the patient experienced fatigue, body aches, low-grade fever, headaches, nausea and malaise. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fatigue, body aches, low-grade fever, headaches, nausea and malaise were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Jan2021 as dose 2, single (Lot number: EK9231), in left arm and on 04Oct2021 as dose 3 (booster), single (Lot number: 30155BA) at the age of 50 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High cholesterol" (unspecified if ongoing). The patient had no known allergies. Concomitant medication(s) included: ATORVASTATIN, stop date: 10Dec2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible. No further information is expected.
Throat felt like burning; Body temperature raised; Dizzy; Loss of taste; Loss of smell; Chills are so strong felt they're killing patient; Body aches; Tired of speaking; Headache; Arm swelled a little; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swelled a little), THROAT IRRITATION (Throat felt like burning), PYREXIA (Body temperature raised), DIZZINESS (Dizzy) and AGEUSIA (Loss of taste) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jul-2021, the patient experienced PERIPHERAL SWELLING (Arm swelled a little). On 07-Aug-2021, the patient experienced THROAT IRRITATION (Throat felt like burning), PYREXIA (Body temperature raised), DIZZINESS (Dizzy), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), CHILLS (Chills are so strong felt they're killing patient), PAIN (Body aches), FATIGUE (Tired of speaking) and HEADACHE (Headache). On 30-Jul-2021, PERIPHERAL SWELLING (Arm swelled a little) had resolved. At the time of the report, THROAT IRRITATION (Throat felt like burning), PYREXIA (Body temperature raised), DIZZINESS (Dizzy), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), CHILLS (Chills are so strong felt they're killing patient), PAIN (Body aches), FATIGUE (Tired of speaking) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter  No treatment medication were provided by the reporter
Mother and pt into office the morning after immunization given the evening before. Mother states pt complained of shortness of breath and difficulty sleeping, couldn't get comfortable. Referred to ER. Per mother about 1 hour later pt given steroids, Benadryl, released to go home.
Fussiness & diaphoresis 3 days p/3rd DTP/HIB; pt exp pallor also; 40 mins period of limpness & poor responsiveness 4 days p/vax; no fever;
Information has been received from a physician concerning a 25 year old female patient who on an unspecified date was vaccinated intramuscularly with the third dose of GARDASIL, 0.5 ml, (lot # not reported). The physician reported that on 10-NOV-2011, the patient experienced "seizure like reactions, muscle aches, weakness and her lips were tingling". The patient did not seek medical attention, no treatment for the adverse events was given. The patient recovered from seizure like reactions, muscle aches, weakness and lips tingling on 12-NOV-2011. Upon internal review, seizure like reactions was considered to be an other important medical event. Additional information has been requested.
expired Adacel vaccine administered with no reported adverse event; Initial information received on 06-Jul-2023 regarding an unsolicited valid non-serious case received from a nurse.  This case involves 34 years old male patient for whom expired diphtheria-2/tetanus/5 AC pertussis vaccine [Adacel] was administered with no reported adverse event   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 05-Jul-2023, the patient received a standard expired dose of suspect diphtheria-2/tetanus/5 AC pertussis vaccine Suspension for injection at a dose of 0.5 mL total (lot U7093AA, expiry date- 18-JUN-2023) via intramuscular route in the left deltoid for Immunization with no reported adverse event (expired product administered) (latency- same day).  Reportedly, Nurse called to report that a patient was given an expired ADACEL injection and asked for guidelines regarding this.  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Red blotches on skin, chest pain, ear pain, sore throat, cough, fatigue, chills, increased thirst, increased sweating
Spotting menstruatal cycle - 2 weeks early than normal. Light but dark in color and severe cramping
after the injection she felt like liquid was running through her; Numbness and tingling on left side; Numbness and tingling on left side; No sleep; two fingers and toes numb and ice cold; two fingers and toes numb and ice cold; Two fingers on left hand swollen; redness in left arm that was painful; Redness in left arm that was painful; Constant pain; This spontaneous case was reported by a patient and describes the occurrence of SENSATION OF BLOOD FLOW (after the injection she felt like liquid was running through her), HYPOAESTHESIA (Numbness and tingling on left side), PARAESTHESIA (Numbness and tingling on left side), PAIN (Constant pain) and INSOMNIA (No sleep) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PAIN (Constant pain). On an unknown date, the patient experienced SENSATION OF BLOOD FLOW (after the injection she felt like liquid was running through her), HYPOAESTHESIA (Numbness and tingling on left side), PARAESTHESIA (Numbness and tingling on left side), INSOMNIA (No sleep), HYPOAESTHESIA (two fingers and toes numb and ice cold), PERIPHERAL COLDNESS (two fingers and toes numb and ice cold), PERIPHERAL SWELLING (Two fingers on left hand swollen), VACCINATION SITE PAIN (redness in left arm that was painful) and VACCINATION SITE ERYTHEMA (Redness in left arm that was painful). At the time of the report, SENSATION OF BLOOD FLOW (after the injection she felt like liquid was running through her), HYPOAESTHESIA (Numbness and tingling on left side), PARAESTHESIA (Numbness and tingling on left side), PAIN (Constant pain), INSOMNIA (No sleep), HYPOAESTHESIA (two fingers and toes numb and ice cold), PERIPHERAL COLDNESS (two fingers and toes numb and ice cold), PERIPHERAL SWELLING (Two fingers on left hand swollen), VACCINATION SITE PAIN (redness in left arm that was painful) and VACCINATION SITE ERYTHEMA (Redness in left arm that was painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Jul2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 47 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Poor immune system response after bout with infectious disease (not HIV)" (unspecified if ongoing); "known allergies: Sulfa" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive, notes: Treatment of COVID-19; (Sep2022) Positive, notes: Rebound string positive COVID test results and symptom recurrence after 4 days of ending. Patient did not receive any other medication in 2 weeks. Therapeutic measures were taken as a result of covid-19 which include Paxlovid from 28Aug2022 to 01Sep2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient is a 68 yo male s/p full Pfizer COVID-19 vaccination: dose 1 on 3/8 and dose 2 on 3/29. PMH of multiple myeloma last treatment on 7/21/2021 with VRd, HTN, diabetes. Presents to the ED on 7/28 for fatigue, SOB, weakness, lightheadedness, fever. He had known COVID exposure on 7/23. Rapid test resulted positive and patient admitted to the hospital on 7/28. Empirically treated with cefepime + doxycycline, then ceftriaxone, then Augmentin due to immunocompromised status. Discharged from hospital on 8/2.
03/31/2021 received 1st dose of Moderna COVID-19 vaccine 04/01/2021 104 F fever, dizziness, nausea 04/03/2021 symptoms subsided 04/04/2021 case expired as a result of undetermined natural causes per medical examiner final report
The patients did not experience any symptoms; patient was vaccinated with improperly stored varivax; This spontaneous report as received from a medical assistant refers to a 12 months old female patient. The patient's pertinent medical history and drug reactions or allergies were not reported. The patient's concomitant therapy included sterile diluent. On 10-JAN-2020, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) for prophylaxis (strength, dose, route of administration and anatomical location were not reported) of lot # S006647 is an invalid lot number, expiry date reported as 05-MAR-2021 for prophylaxis (product storage error). The patient did not experience any symptoms. The outcome of product storage error was unknown. The temperature excursion for varicella virus vaccine live (oka/merck) (VARIVAX) was reported as -9 degrees Celsius (C) to 8 degrees Celsius (3.3 C) for 53 hours. There was no previous temperature excursion reported. Data logger was involved. No product quality complaint (PQC) was associated with this report.  This is one of the multiple reports from the same reporter.; Sender's Comments:  US-009507513-1911USA011629:
Patient received Bexsero instead of Engerix; 2 month old patient received bexsero; Received BEXSERO in left thigh; This case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 2-month-old female patient who received Men B NVS (Bexsero) (batch number ABXB59AA, expiry date 30th September 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 7th March 2022, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 7th March 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced wrong vaccine administered, inappropriate age at vaccine administration and vaccine administered at inappropriate site. On an unknown date, the outcome of the wrong vaccine administered, inappropriate age at vaccine administration and vaccine administered at inappropriate site were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details reported were as follows: The 2 month old patient received Bexsero instead of Engerix, which led to wrong vaccine administered and inappropriate age at vaccine administration. The vaccine was administered by experienced MA (medical Assistant). The patient received Bexsero in left thigh, which led to vaccine administered at inappropriate site.
Developed swelling, warmth and tenderness with some induration (about the size of a golfball) on left thigh. Family visiting out of town when mom called-rec. getting seen for it.
This spontaneous report as received from a nurse practitioner refers to an unspecified number of patients unknown age and gender. No concurrent conditions and medical history were reported. The nurse practitioner reported that, on an unknown date, the patient's received improperly stored doses of (Oka/Merck) VARIVAX (lot # L006384, expiration date 25-FEB-2017 and lot # reported as K023008, expiration date 25-SEP-2017)which were exposed to temperature range of 90F to 100F (route and dose were not reported). No concomitant medication were reported. No adverse effects were reported. Lot # K023008 is not valid for (Oka/Merck) VARIVAX. Additional information has been requested.